Connect Biopharma Holdings Limited Effective Tax Rate
Connect Biopharma Holdings Limited (CNTB) reported Effective Tax Rate of -0.30% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-12
- Connect Biopharma Holdings Limited effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was -0.30%.
- Connect Biopharma Holdings Limited effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was -0.20%.
- Connect Biopharma Holdings Limited effective income tax rate reconciliation, percent for the quarter ending 2025-09-30 was -0.40%.
- Connect Biopharma Holdings Limited effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was -0.40%, a 300.00% decline year-over-year.
- Connect Biopharma Holdings Limited effective income tax rate reconciliation, percent for fiscal 2025 was -0.30%.
- Connect Biopharma Holdings Limited effective income tax rate reconciliation, percent for fiscal 2024 was -1.50%.
- Connect Biopharma Holdings Limited effective income tax rate reconciliation, percent for fiscal 2023 was -0.20%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -0.30% 10-Q · filed 2026-08-12 | -0.30% 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -0.20% 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | -0.30% 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -0.40% 10-Q · filed 2025-11-12 | -0.40% 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | -0.40% 10-Q · filed 2026-08-12 | -0.50% 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | -0.50% 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | -1.50% 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -0.40% 10-Q · filed 2025-11-12 | -1.80% 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | 0.20% 10-Q · filed 2025-08-13 | 1.00% 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -0.30% 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -0.20% 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |